The Evolution of SEND at AstraZeneca.
Saved in:
| Title: | The Evolution of SEND at AstraZeneca. |
|---|---|
| Authors: | Kent C; Regulatory Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK. Electronic address: SEND-Data-Management@astrazeneca.com., Coupland B; Regulatory Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK. Electronic address: SEND-Data-Management@astrazeneca.com., Barnard C; Regulatory Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Alderley Park, UK. Electronic address: SEND-Data-Management@astrazeneca.com., Schofield J; Data Science & AI, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK. Electronic address: SEND-Data-Management@astrazeneca.com., Afif-Rider S; Regulatory Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, USA. Electronic address: SEND-Data-Management@astrazeneca.com. |
| Source: | Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2021 Jul; Vol. 123, pp. 104954. Date of Electronic Publication: 2021 May 08. |
| Publication Type: | Journal Article; Comment |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8214983 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0295 (Electronic) Linking ISSN: 02732300 NLM ISO Abbreviation: Regul Toxicol Pharmacol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
